 |
市場調查報告書
商品編碼
1705861
全球藥物濫用治療市場按類型、治療類型、年齡層、治療環境和地區分類Global Substance Abuse Treatment Market, By Type, By Treatment Type, By Age Group, By Treatment Setting, By Geography |
||||||
價格
簡介目錄
預計 2025 年全球藥物濫用治療市場規模為 118.2 億美元，到 2032 年將達到 213.3 億美元，2025 年至 2032 年的複合年成長率為 8.8%。
| 報告範圍 | 報告詳細資訊 | ||
|---|---|---|---|
| 基準年 | 2024 | 2025年的市場規模 | 118.2億美元 |
| 效能數據 | 從2020年到2024年 | 預測期 | 2025年至2032年 |
| 預測期：2025-2032年複合年成長率： | 8.80% | 2032年價值預測 | 213.3億美元 |
數字。 2025年全球市場佔有率（按地區分類）
藥物濫用治療是指旨在控制藥物依賴並幫助人們實現長期戒酒和康復的計劃和活動。物質濫用障礙，也稱為成癮，是指強迫性或無法控制地使用有害和成癮物質，儘管這些物質有負面影響。常見的濫用物質包括酒精、鴉片類藥物、大麻、古柯鹼和興奮劑。物質濫用疾患的主要症狀包括無法減少攝取量、產生渴望、不使用時出現戒斷症狀。成癮者通常會經歷自我控制能力下降、社交問題、危險使用，有時會產生身體依賴。藥物濫用治療旨在透過治療性介入、諮商、藥物治療和社區支持計畫來解決成癮的生物、心理、社會和行為方面。全球範圍內藥物濫用率的上升刺激了對有效治療方案的需求。
市場動態：
全球藥物濫用治療市場受到藥物濫用障礙盛行率上升、對治療有效性認知不斷提高、有利的監管和報銷政策以及新型藥物輔助治療產品的推出的推動。然而，與成癮相關的社會恥辱、低收入地區缺乏治療設施以及違規治療通訊協定等問題可能會抑制市場成長。數位化治療解決方案、綜合護理模式、針對特定成癮的針對性治療以及向新興市場的擴張為市場參與者帶來了重大商機。從地區來看，北美憑藉先進的醫療保健基礎設施和醫療意識佔據市場主導地位。然而，預計亞太地區在預測期內將出現良好的成長。
本研究的主要特點
- 本報告對全球藥物濫用治療市場進行了詳細分析，並提供了預測期（2025-2032）的市場規模和年複合成長率(CAGR)，假設 2024 年為基準年。
- 它還強調了各個領域的潛在收益成長機會，並說明了該市場的引人注目的投資提案矩陣。
- 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的主要考察。
- 它根據公司亮點、產品系列、關鍵亮點、財務業績和策略等參數，對全球藥物濫用治療市場的主要企業進行了概述。
- 本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
- 全球藥物濫用治療市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
- 相關人員將透過用於分析全球藥物濫用治療市場的各種策略矩陣更輕鬆地做出決策。
目錄
第1章 調查目的與前提條件
- 研究目標
- 先決條件
- 簡稱
第2章 市場展望
- 報告描述
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章市場動態、法規與趨勢分析
- 市場動態
- 驅動程式
- 藥物和酒精消費量增加
- 政府和非政府組織的支持不斷增加
- 限制因素
- 與藥物成癮相關的社會恥辱
- 缺乏合適的復健設施
- 機會
- 新興國家尚未開發的市場
- 公司市場佔有率分析
- 主要亮點
- 市場趨勢
- PEST分析
- 波特分析
- 最近的產品核可/發布
- 合併、收購和合作
4. 全球藥物濫用治療市場-冠狀病毒（COVID-19）大流行的影響
- COVID-19流行病學
- 供需側分析
- 經濟影響
5. 2020 年至 2032 年全球藥物濫用治療市場（按類型）
- 酒精
- 鴉片類藥物（例如海洛因、處方止痛藥）
- 煙草/尼古丁
- 古柯鹼
- 大麻
- 甲基安非他命
- 其他非法藥物（如苯二氮平類藥物）
6. 2020 年至 2032 年按治療類型分類的全球藥物濫用治療市場
- 鴉片類藥物
- 美沙酮
- Buprenornhine
- 緩釋性納曲酮
- 洛非西定
- 尼古丁
- 尼古丁替代療法（可使用貼片、吸入器和口香糖）
- 安非他酮
- Varenicline
- 酒精
- 納曲酮
- Disulfiram
- Acamprosate
- 菸草
- 可樂定
- 去甲替林
- 其他（托吡酯、Modafinil非尼等）
7. 2020 年至 2032 年按年齡族群分類的全球藥物濫用治療市場
- 青年
- 成人
- 老年人
8. 2020 年至 2032 年全球藥物濫用治療市場（依治療環境分類）
- 門診治療
- 門診
- 私人診所
- 住院治療
- 復健中心
- 醫院
- 住宅治療設施
- 戒毒中心
9. 2020 年至 2032 年全球藥物濫用治療市場（按地區）
- 北美洲
- 歐洲
- 亞太地區
- 拉丁美洲
- 中東
- 非洲
第10章 競爭格局
- 公司簡介
- Indivior PLC
- Pfizer, Inc.
- Johnson &Johnson Inc.
- Mallinckrodt Pharmaceuticals
- Teva Pharmaceuticals, Inc.
- Par Pharmaceutical, Inc.
- USWM, LLC
- Valeant Pharmaceuticals
- Greenyard Pharmaceutical Ltd
- Cipla Health Limited
- Perrigo
- Haleon Group of Companies
- Ventus Medical
- Glenmark
- Other Prominent Players
第 11 章 章節
- 參考
- 調查方法
- 關於出版商
簡介目錄
Product Code: CMI6671
Global Substance Abuse Treatment Market is estimated to be valued at USD 11.82 Bn in 2025 and is expected to reach USD 21.33 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 11.82 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 8.80% | 2032 Value Projection: | USD 21.33 Bn |
Figure. Global Substance Abuse Treatment Market Share (%), By Region 2025
Substance abuse treatment refers to programs and activities that are aimed at managing substance dependence and support long-term sobriety and recovery. Substance abuse disorder which is also known as addiction, involves the compulsive or uncontrollable use of harmful and addictive substances despite their negative impact. Common substances of abuse include alcohol, opioids, cannabis, cocaine, and methamphetamines. Some key signs of substance abuse disorder include the inability to reduce intake, experiencing cravings, and having withdrawal symptoms when not using. Those suffering from addiction often experience impaired control, social problems, risky use, and sometimes even physical dependence. Substance abuse treatment aims to address the biological, psychological, social, and behavioral aspects of addiction through therapeutic interventions, counseling, medication, and community support programs. The rise in substance abuse rates globally is fueling demand for effective treatment options.
Market Dynamics:
Global substance abuse treatment market is driven by the rising prevalence of substance abuse disorders, increasing awareness regarding treatment availability, favorable regulations and reimbursement policies, and the launch of novel medication-assisted treatment products. However, the market growth can be restrained by social stigmas that are associated with addiction, lack of access to treatment facilities in low-income regions, and non-compliance issues with treatment protocols. The development of digital therapeutic solutions, integrated care models, targeted therapies for specific addictions, and expansion to emerging markets present key opportunities for the market players. Geographically, North America dominates the market due to advanced healthcare infrastructure and awareness. However, the Asia Pacific region is expected to offer lucrative growth prospects during the forecast period.
Key Features of the Study:
- This report provides an in-depth analysis of the global substance abuse treatment market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year.
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global substance abuse treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Indivior PLC, Pfizer, Inc., Johnson & Johnson Inc., Alkermes., Mallinckrodt Pharmaceuticals, Teva Pharmaceuticals, Inc., Par Pharmaceutical, Inc., USWM, LLC, Valeant Pharmaceuticals, Greenyard Pharmaceutical Ltd. Cipla Health Limited. Perrigo, Haleon Group of Companies, Ventus Medical, Glenmark and other prominent players.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global substance abuse treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global substance abuse treatment market.
Detailed Segmentation:
- Global Substance Abuse Treatment Market, By Type
- Alcohol
- Opioids (e.g., heroin, prescription painkillers)
- Tobacco/nicotine
- Cocaine
- Marijuana
- Methamphetamines
- Other illicit drugs (Benzodiazepines, etc.)
- Global Substance Abuse Treatment Market, By Treatment Type
- Opioid
- Methadone
- Buprenorphine
- Extended-release naltrexone
- Lofexidine
- Nicotine
- Nicotine replacement therapies (available as a patch, inhaler, or gum)
- Bupropion
- Varenicline
- Alcohol
- Naltrexone
- Disulfiram
- Acamprosate
- Tobacco
- Clonidine
- Nortriptyline
- Others (Topiramate, Modafinil, etc.)
- Global Substance Abuse Treatment Market, By Age Group
- Adolescents
- Adults
- Geriatric
- Global Substance Abuse Treatment Market, By Treatment Setting
- Outpatient Treatment
- Outpatient Clinics
- Private Practices
- Inpatient Treatment
- Rehabilitation Centers
- Hospitals
- Residential Treatment Facilities
- Detoxification Centers
- Global Substance Abuse Treatment Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles
- Indivior PLC
- Pfizer, Inc.
- Johnson & Johnson Inc.
- Mallinckrodt Pharmaceuticals
- Teva Pharmaceuticals, Inc.
- Par Pharmaceutical, Inc.
- USWM, LLC
- Valeant Pharmaceuticals
- Greenyard Pharmaceutical Ltd
- Cipla Health Limited
- Perrigo
- Haleon Group of Companies
- Ventus Medical
- Glenmark
- Other Prominent Players
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Type
- Market Snippet, By Treatment Type
- Market Snippet, By Age Group
- Market Snippet, By Treatment Setting
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers:
- Increasing consumption of drugs and alcohol
- Growing support from government and NGOs
- Restraints
- Social stigma associated with substance dependence
- Lack of adequate rehabilitation facilities
- Opportunities
- Untapped markets in developing countries
- Company Market Share Analysis
- Key Highlights
- Market Trends
- PEST Analysis
- PORTER's Analysis
- Recent Product Approvals/Launches
- Mergers, Acquisitions, and Collaborations
4. Global Substance Abuse Treatment Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Substance Abuse Treatment Market, By Type, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Alcohol
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Opioids (e.g., heroin, prescription painkillers)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Tobacco/nicotine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Cocaine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Marijuana
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Methamphetamines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Other illicit drugs (Benzodiazepines, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
6. Global Substance Abuse Treatment Market, By Treatment Type, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Opioid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Methadone
- Buprenorphine
- Extended-release naltrexone
- Lofexidine
- Nicotine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Nicotine replacement therapies (available as a patch, inhaler, or gum)
- Bupropion
- Varenicline
- Alcohol
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Naltrexone
- Disulfiram
- Acamprosate
- Tobacco
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Clonidine
- Nortriptyline
- Others (Topiramate, Modafinil, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
7. Global Substance Abuse Treatment Market, By Age Group, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Adolescents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
8. Global Substance Abuse Treatment Market, By Treatment Setting, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Outpatient Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Outpatient Clinics
- Private Practices
- Inpatient Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Rehabilitation Centers
- Hospitals
- Residential Treatment Facilities
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Detoxification Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
9. Global Substance Abuse Treatment Market, By Region, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2032
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profile
- Indivior PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pfizer, Inc.
- Johnson & Johnson Inc.
- Mallinckrodt Pharmaceuticals
- Teva Pharmaceuticals, Inc.
- Par Pharmaceutical, Inc.
- USWM, LLC
- Valeant Pharmaceuticals
- Greenyard Pharmaceutical Ltd
- Cipla Health Limited
- Perrigo
- Haleon Group of Companies
- Ventus Medical
- Glenmark
- Other Prominent Players
- Analyst Views
11. Section
- References
- Research Methodology
- About us
